UHC 2.0: Charting a Course to Sustainable Healthcare and Finance in the Asia-Pacific

The report argues that traditional Universal Health Coverage (UHC 1.0) models are no longer fit for the Asia-Pacific due to ageing populations and rising non-communicable diseases. It advocates for 'UHC 2.0', which emphasizes decentralized, tech-enabled delivery and innovative financing like social impact bonds and public-private partnerships, with detailed analysis for Australia, India, Japan, and Viet Nam.

• The Asia-Pacific region faces critical sustainability challenges for healthcare due to an ageing population, the rise of communicable and non-communicable diseases, and the fragility of systems exposed by the COVID-19 pandemic.
• Traditional healthcare financing based on taxation and social insurance is becoming unsustainable in the region due to shrinking taxable workforces and large informal employment sectors.
• Life-course immunization (LCI) is highly cost-effective but suffers from low adult uptake in the Asia-Pacific, driven by low awareness, vaccine scepticism among practitioners, and limited accessibility.
• Diabetes management in the region is hindered by a lack of early diagnostics—with up to 50% of cases remaining undiagnosed—and a lack of support for patient self-management.
• Rare diseases are severely under-prioritized in the region, with patients often facing diagnostic delays of up to seven years and limited access to approved treatments.
• UHC 2.0 delivery solutions should shift from physical centralization to virtual infrastructure, utilizing AI, blockchain, and wearables to improve patient experience and resource allocation.
• Sustainable financing for UHC 2.0 requires moving beyond taxes to include social impact bonds (SIBs), crowdfunding, and 'sin taxes' on products like sugar and tobacco.
• In India, the healthcare system is challenged by a very large informal workforce (around 80%) that is not captured by the tax system and struggles to enroll in social health insurance.
• Japan's 'super-aged' status, with 28% of the population over 65, threatens the sustainability of its generous public insurance system due to rising costs and a shrinking workforce.
• Viet Nam faces significant gaps in rare disease care, including a lack of a national strategy and limited public reimbursement for orphan drugs, such as a 30% rate for Myozyme.

APA

World Economic Forum (2021). UHC 2.0: Charting a Course to Sustainable Healthcare and Finance in the Asia-Pacific. https://www3.weforum.org/docs/WEF_Charting_a_Course_to_Sustainable_Healthcare_and_Finance_in_the_Asia_Pacific_2021.pdf

Chicago

World Economic Forum. UHC 2.0: Charting a Course to Sustainable Healthcare and Finance in the Asia-Pacific. 2021. https://www3.weforum.org/docs/WEF_Charting_a_Course_to_Sustainable_Healthcare_and_Finance_in_the_Asia_Pacific_2021.pdf.

Wikipedia

{{cite report |author=World Economic Forum |title=UHC 2.0: Charting a Course to Sustainable Healthcare and Finance in the Asia-Pacific |date=October 2021 |url=https://www3.weforum.org/docs/WEF_Charting_a_Course_to_Sustainable_Healthcare_and_Finance_in_the_Asia_Pacific_2021.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}

BibTeX

@techreport{worldeconomicforum2021uhc, author = {{World Economic Forum}}, title = {{UHC 2.0: Charting a Course to Sustainable Healthcare and Finance in the Asia-Pacific}}, institution = {World Economic Forum}, year = {2021}, month = oct, url = {https://www3.weforum.org/docs/WEF_Charting_a_Course_to_Sustainable_Healthcare_and_Finance_in_the_Asia_Pacific_2021.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }